4.8 Article

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

Related references

Note: Only part of the references are listed.
Article Tropical Medicine

The changing epidemiology of human monkeypox—A potential threat? A systematic review

Eveline M. Bunge et al.

PLoS Neglected Tropical Diseases (2022)

Review Biochemistry & Molecular Biology

Monkeypox: A New Threat?

Dorota Kmiec et al.

Summary: The global smallpox vaccination programme successfully eliminated the virus, but the halted vaccination and increasing susceptibility have led to the spread of monkeypox virus. Monkeypox virus, a close relative of smallpox virus, can be cross-protected by smallpox vaccines. However, over 70% of people have never been vaccinated against smallpox. Monkeypox symptoms include fever, headache, muscle ache, and characteristic rash, with lower fatality rates compared to smallpox. Monkeypox virus is endemic in sub-Saharan Africa and spreads through exotic animal trade and international travel.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, General & Internal

Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2

Florian Pfaff et al.

LANCET (2022)

Review Immunology

Immunosenescence in atherosclerosis: A role for chronic viral infections

Atefe Ghamar Talepoor et al.

Summary: Immune system aging and atherosclerosis share common drivers, such as inflammation and chronic viral infections. Several DNA and RNA viruses are stimulators of both immunosenescence and atherosclerosis. The newly emerged SARS-CoV-2 virus can induce immune aging and atherosclerosis, as well as cause inflammation.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Immunosenescence, aging and successful aging

Yunan Wang et al.

Summary: Immunosenescence, the immune related changes caused by aging, plays crucial roles in various age-related diseases, including neurodegenerative diseases, tumors, cardiovascular diseases, autoimmune diseases, and COVID-19. However, the mechanisms, association with aging and successful aging, as well as the effects on diseases, are not clearly understood. This review highlights the involvement of aging-related phenotypic changes, deterioration of immune organ function, and alterations of immune cell subsets in the process of immunosenescence, which significantly impact the occurrence and development of age-related diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

James M. Tesoriero et al.

Summary: This cohort study conducted in New York State found that persons living with diagnosed HIV had poorer outcomes related to COVID-19 compared to persons living without diagnosed HIV. Previous HIV diagnosis was associated with higher rates of severe disease requiring hospitalization, and hospitalization risk increased with progression of HIV disease stage.

JAMA NETWORK OPEN (2021)

Letter Immunology

SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

Seth A. Hoffman et al.

Summary: The study reveals that patients with HIV/AIDS may carry variants of SARS-CoV-2 that are resistant to neutralization, highlighting the importance of monitoring infections in immunocompromised individuals.

EMERGING INFECTIOUS DISEASES (2021)

Article Immunology

Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020

Phi-Yen Nguyen et al.

Summary: The monkeypox outbreak in Nigeria from 2017 to 2020 serves as a case study for emerging zoonoses, with declining immunity contributing to the substantial resurgence of the disease. Factors such as population growth, accumulation of unvaccinated cohorts, and decline in smallpox vaccine immunity were identified as key drivers for the renewed outbreak.

EMERGING INFECTIOUS DISEASES (2021)

Review Medicine, General & Internal

COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies

Muhammad Yousaf et al.

Summary: Our research highlights the risk of prolonged viral shedding in COVID-19 patients and its implications for isolation strategies, as well as explores possible solutions through PCR-CT value testing. Additionally, we review the impact of HIV on COVID-19.

CLINICAL CASE REPORTS (2021)

Article Immunology

Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018

Aisling Vaughan et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Evidence for Residual Immunity to Smallpox After Vaccination and Implications for Re-emergence

Mohana Priya Kunasekaran et al.

MILITARY MEDICINE (2019)

Article Biochemistry & Molecular Biology

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

Iuliia Gilchuk et al.

Article Medicine, General & Internal

Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study

Dennis D. Taub et al.

AMERICAN JOURNAL OF MEDICINE (2008)

Article Immunology

Clinical characteristics of human monkeypox, and risk factors for severe disease

GD Huhn et al.

CLINICAL INFECTIOUS DISEASES (2005)

Article Biochemistry & Molecular Biology

Duration of antiviral immunity after smallpox vaccination

E Hammarlund et al.

NATURE MEDICINE (2003)

Article Multidisciplinary Sciences

Transmission potential of smallpox in contemporary populations

R Gani et al.

NATURE (2001)